Note: Rate any residual disability of infection within the appropriate body system as indicated by the notes in the evaluation criteria. As applicable, consider the long-term health effects potentially associated with infectious diseases as listed in § 3.317(d) of this chapter, specifically Brucellosis, Campylobacter jejuni, Coxiella burnetii (Q fever), Malaria, Mycobacterium Tuberculosis, Nontyphoid Salmonella, Shigella, Visceral Leishmaniasis, and West Nile virus.
| Description | Rating |
|---|---|
| 6314 Beriberi: | |
| As active disease: | |
| With congestive heart failure, anasarca, or Wernicke-Korsakoff syndrome | 100 |
| With cardiomegaly, or; with peripheral neuropathy with footdrop or atrophy of thigh or calf muscles | 60 |
| With peripheral neuropathy with absent knee or ankle jerks and loss of sensation, or; with symptoms such as weakness, fatigue, anorexia, dizziness, heaviness and stiffness of legs, headache or sleep disturbance | 30 |
| Thereafter rate residuals under the appropriate body system. |